Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Accumulated Expenses (2018 - 2019)

DiaMedica Therapeutics (DMAC) has 2 years of Accumulated Expenses data on record, last reported at $299000.0 in Q3 2019.

  • For Q3 2019, Accumulated Expenses changed N/A year-over-year to $299000.0; the TTM value through Sep 2019 reached $299000.0, changed N/A, while the annual FY2018 figure was $808000.0, N/A changed from the prior year.
  • Accumulated Expenses reached $299000.0 in Q3 2019 per DMAC's latest filing, down from $630000.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $808000.0 in Q4 2018 and bottomed at $299000.0 in Q3 2019.